novo nordisk wegovy - Search News

News

Novo Nordisk, Wegovy

Novo Nordisk shares pop as drugmaker sees copycat Wegovy sales easing in 2025

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Reuters on MSN · 2d

Novo Nordisk hopes to see US Wegovy sales recover soon

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month, its CEO said on Wednesday after the company cut its 2025 forecasts.

Pharmaceutical Technology on M… · 2d

Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand

Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and diabetes drugs.

Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

2don MSN

Novo Nordisk Gains as CFO Touts Wegovy’s Rebound Potential

Novo Nordisk A/S surged on expectations that some competition for its blockbuster obesity shot Wegovy will subside, paving ...

Wegovy Deal Makes Cofounder Of Hair Loss Pill Seller Hims A Billionaire

Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...

Top Analyst Reports for Novo Nordisk, Honeywell & American Tower

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Honeywell ...

Novo Nordisk Guidance in Focus Amid Stagnant Prescription Trends -- Earnings Preview

--The company currently guides for 16%-24% sales growth at constant exchange rates and for 19%-27% operating profit growth. "With the continued weak trends in the U.S. continuing into 2Q, we now ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results